CIRM Alpha Stem Cell Clinics: Collaboratively Addressing Regenerative Medicine Challenges

Catriona H.M. Jamieson, Maria T. Millan, Abla A. Creasey, Geoff Lomax, Mary E. Donohoe, Mark C. Walters, Mehrdad Abedi, Daniela A. Bota, John A. Zaia, John S. Adams

Research output: Contribution to journalComment/debate

1 Citation (Scopus)

Abstract

The California Institute for Regenerative Medicine (CIRM) Alpha Stem Cell Clinic (ASCC) Network was launched in 2015 to address a compelling unmet medical need for rigorous, FDA-regulated, stem cell-related clinical trials for patients with challenging, incurable diseases. Here, we describe our multi-center experiences addressing current and future challenges. The California Institute for Regenerative Medicine (CIRM) Alpha Stem Cell Clinic (ASCC) Network was launched in 2015 to address a compelling unmet medical need for rigorous, FDA-regulated, stem cell-related clinical trials for patients with challenging, incurable diseases. Here, we describe our multi-center experiences addressing current and future challenges.

Original languageEnglish (US)
Pages (from-to)801-805
Number of pages5
JournalCell Stem Cell
Volume22
Issue number6
DOIs
StatePublished - Jun 1 2018

Fingerprint

Regenerative Medicine
Stem Cells
Clinical Trials

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Cell Biology

Cite this

Jamieson, C. H. M., Millan, M. T., Creasey, A. A., Lomax, G., Donohoe, M. E., Walters, M. C., ... Adams, J. S. (2018). CIRM Alpha Stem Cell Clinics: Collaboratively Addressing Regenerative Medicine Challenges. Cell Stem Cell, 22(6), 801-805. https://doi.org/10.1016/j.stem.2018.05.007

CIRM Alpha Stem Cell Clinics : Collaboratively Addressing Regenerative Medicine Challenges. / Jamieson, Catriona H.M.; Millan, Maria T.; Creasey, Abla A.; Lomax, Geoff; Donohoe, Mary E.; Walters, Mark C.; Abedi, Mehrdad; Bota, Daniela A.; Zaia, John A.; Adams, John S.

In: Cell Stem Cell, Vol. 22, No. 6, 01.06.2018, p. 801-805.

Research output: Contribution to journalComment/debate

Jamieson, CHM, Millan, MT, Creasey, AA, Lomax, G, Donohoe, ME, Walters, MC, Abedi, M, Bota, DA, Zaia, JA & Adams, JS 2018, 'CIRM Alpha Stem Cell Clinics: Collaboratively Addressing Regenerative Medicine Challenges', Cell Stem Cell, vol. 22, no. 6, pp. 801-805. https://doi.org/10.1016/j.stem.2018.05.007
Jamieson CHM, Millan MT, Creasey AA, Lomax G, Donohoe ME, Walters MC et al. CIRM Alpha Stem Cell Clinics: Collaboratively Addressing Regenerative Medicine Challenges. Cell Stem Cell. 2018 Jun 1;22(6):801-805. https://doi.org/10.1016/j.stem.2018.05.007
Jamieson, Catriona H.M. ; Millan, Maria T. ; Creasey, Abla A. ; Lomax, Geoff ; Donohoe, Mary E. ; Walters, Mark C. ; Abedi, Mehrdad ; Bota, Daniela A. ; Zaia, John A. ; Adams, John S. / CIRM Alpha Stem Cell Clinics : Collaboratively Addressing Regenerative Medicine Challenges. In: Cell Stem Cell. 2018 ; Vol. 22, No. 6. pp. 801-805.
@article{3a7f2aa3e17f4d279ac3257aaab3a8b5,
title = "CIRM Alpha Stem Cell Clinics: Collaboratively Addressing Regenerative Medicine Challenges",
abstract = "The California Institute for Regenerative Medicine (CIRM) Alpha Stem Cell Clinic (ASCC) Network was launched in 2015 to address a compelling unmet medical need for rigorous, FDA-regulated, stem cell-related clinical trials for patients with challenging, incurable diseases. Here, we describe our multi-center experiences addressing current and future challenges. The California Institute for Regenerative Medicine (CIRM) Alpha Stem Cell Clinic (ASCC) Network was launched in 2015 to address a compelling unmet medical need for rigorous, FDA-regulated, stem cell-related clinical trials for patients with challenging, incurable diseases. Here, we describe our multi-center experiences addressing current and future challenges.",
author = "Jamieson, {Catriona H.M.} and Millan, {Maria T.} and Creasey, {Abla A.} and Geoff Lomax and Donohoe, {Mary E.} and Walters, {Mark C.} and Mehrdad Abedi and Bota, {Daniela A.} and Zaia, {John A.} and Adams, {John S.}",
year = "2018",
month = "6",
day = "1",
doi = "10.1016/j.stem.2018.05.007",
language = "English (US)",
volume = "22",
pages = "801--805",
journal = "Cell Stem Cell",
issn = "1934-5909",
publisher = "Cell Press",
number = "6",

}

TY - JOUR

T1 - CIRM Alpha Stem Cell Clinics

T2 - Collaboratively Addressing Regenerative Medicine Challenges

AU - Jamieson, Catriona H.M.

AU - Millan, Maria T.

AU - Creasey, Abla A.

AU - Lomax, Geoff

AU - Donohoe, Mary E.

AU - Walters, Mark C.

AU - Abedi, Mehrdad

AU - Bota, Daniela A.

AU - Zaia, John A.

AU - Adams, John S.

PY - 2018/6/1

Y1 - 2018/6/1

N2 - The California Institute for Regenerative Medicine (CIRM) Alpha Stem Cell Clinic (ASCC) Network was launched in 2015 to address a compelling unmet medical need for rigorous, FDA-regulated, stem cell-related clinical trials for patients with challenging, incurable diseases. Here, we describe our multi-center experiences addressing current and future challenges. The California Institute for Regenerative Medicine (CIRM) Alpha Stem Cell Clinic (ASCC) Network was launched in 2015 to address a compelling unmet medical need for rigorous, FDA-regulated, stem cell-related clinical trials for patients with challenging, incurable diseases. Here, we describe our multi-center experiences addressing current and future challenges.

AB - The California Institute for Regenerative Medicine (CIRM) Alpha Stem Cell Clinic (ASCC) Network was launched in 2015 to address a compelling unmet medical need for rigorous, FDA-regulated, stem cell-related clinical trials for patients with challenging, incurable diseases. Here, we describe our multi-center experiences addressing current and future challenges. The California Institute for Regenerative Medicine (CIRM) Alpha Stem Cell Clinic (ASCC) Network was launched in 2015 to address a compelling unmet medical need for rigorous, FDA-regulated, stem cell-related clinical trials for patients with challenging, incurable diseases. Here, we describe our multi-center experiences addressing current and future challenges.

UR - http://www.scopus.com/inward/record.url?scp=85047211312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047211312&partnerID=8YFLogxK

U2 - 10.1016/j.stem.2018.05.007

DO - 10.1016/j.stem.2018.05.007

M3 - Comment/debate

C2 - 29859170

AN - SCOPUS:85047211312

VL - 22

SP - 801

EP - 805

JO - Cell Stem Cell

JF - Cell Stem Cell

SN - 1934-5909

IS - 6

ER -